Corticotropin-releasing factor (CRF) is involved in regulating somatic pain sensitivity in stress. Exogenous CRF can induce both weakening [15,31] and enhancement [12,16] of somatic pain sensitivity. Although exogenous CRF has been seen to have double effects on pain sensitivity, the results of most studies have provided evidence of suppression of somatic pain sensitivity (an analgesic effect) in both animals [6,9,21] and humans [18,20].The peripheral action of CRF on somatic pain sensitivity has received the most study. Peripheral administration of CRF, both systemically (intravenous [9], intraperitoneal [1], intracardiac [5]) and locally [23], induces analgesic effects both on the background of infl ammation [23] and without infl ammation [9]. The action of CRF is mediated via CRF receptors of types 1 and 2 ( CRF-1 and CRF-2 receptors) [10]. There are few data on the involvement of CRF receptors in mediating the analgesic effect of CRF when given peripherally, and these have been obtained on the background of infl ammation. Use of selective antagonists of CRF receptors have demonstrated the involvement of both CRF-1 and CRF-2 receptors, located on leukocytes, in mediating the analgesic actions of CRF when given locally at the infl ammation site in somatic tissues [22]. Additionally, data have been obtained showing that CRF-1 receptors can contribute to the development of infl ammation-induced hyperalgesia [8,11].Despite the fact that the action of CRF on somatic pain sensitivity is apparent not only in infl ammation, but also in the absence of infl ammation [9,15], there are no data on the involvement of CRF receptors in mediating the peripheral action of CRF on somatic pain sensitivity in normal conditions (in the absence of infl ammation). Our previous studies [2] demonstrated the involvement of CRF-2 receptors in mediating the analgesic effect evoked by systemic administration of CRF in anesthetized rats. Administration of CRF-1 and CRF-2 receptors in mediating this effect in conscious animals has not previously been studied.Corticotrophin-releasing factor (CRF) is involved in regulating pain sensitivity and can elicit analgesic effects in animals and humans. The aim of the present work was to investigate the involvement of types 1 and 2 CRF receptors (CRF-1 and CRF-2 receptors) in mediating the analgesic action of CRF on somatic pain sensitivity when given systemically to conscious rats. Somatic pain sensitivity was tested in terms of the latent period (LP) of the tailfl ick reaction in response to thermal stimulation (the tail fl ick test). The involvement of CRF-1 and CFR-2 receptors was studied by systemic administration of their specifi c antagonists NBI 27914 and astressin 2B, respectively. Systemic administration of CRF increased the latent period of the pain reaction (it had an analgesic effect).